ACCESS AND PRODUCTIVITY OUTCOMES WITH RADIOLOGY TECHNOLOGY IN WESTERN SYDNEY Outcomes despite insufficient indexation, Government funding and workforce shortages
With
Leon Berkovich, CEO
GE HealthCare Australia and New Zealand
Dr Mansoor Parker
Diagnostic & Interventional Radiologist & Founding Partner,
Quantum Radiology, Sydney
SEGMENT
Filmed in Sydney | November 2025
In Western Sydney, there is currently significant growth accompanied by a notable need for cardiovascular support due to the prevalence of related diseases. It is estimated that the population in this area will reach 6 million by 2041.
With this population growth, there is also a pressing shortage of healthcare professionals in Australia, particularly in the field of radiology, where there are not enough radiographers, sonographers, MRI technicians, and nuclear medicine technicians.
Previously, conducting complex imaging studies required the expertise of highly experienced technicians. Nonetheless, advancements in technology have enabled businesses to invest in new CT scanning technologies, from organisations such as GE HealthCare, making available the first of its kind in the Southern Hemisphere.
According to Dr. Mansoor Parker, a Diagnostic and Interventional Radiologist in Western Sydney and Founder of Quantum Radiology, the technology can produce consistent, high-quality studies that do not solely rely on the skill of the technician.
Dr. Parker spoke to Australian Health Journal about the unique nature of Western Sydney as a cultural melting pot that has historically suffered from a lack of high-quality healthcare. His motivation for establishing radiology practices in this area stemmed from his own experiences of limited access to imaging services, especially MRI and interventional procedures.
He notes that the challenges faced by the population often go beyond mere accessibility, including language barriers and the need for culturally sensitive care that respects privacy while delivering high standards of healthcare.
According to Leon Berkovich, CEO of GE HealthCare Australia & New Zealand, GE HealthCare has excelled in obtaining AI patents within the imaging sector, demonstrating significant technological adoption in Australia—a mature market where clinicians are eager to integrate the latest technology across all areas. The growth in Western Sydney continues to highlight the urgent need for cardiovascular imaging services, and demographic projections indicate robust population increases.
Source: Adapted from transcript
You Might also like
-
Misinformation impacts routine vaccines
More significant changes in recent years have been health-related misinformation eroding trust in healthcare professionals, leading to people seeking alternative treatments or avoiding medical advice altogether. This can make it more difficult for healthcare professionals to provide effective treatment and care.
Recent vaccines delivered as part of the COVID-19 response, are having a consequential impact on the uptake of routine vaccines.
Australian Health Journal spoke with Dr Paul Griffin, an Infectious Diseases Physician and Microbiologist at Mater Health, and who has been involved in over 150 clinical trials in the field of infectious disease.
Paul talks about the importance of having reputable sources of information that can used to encourage people to understand what is involved in clinical trials and the roles of vaccines.
-
Study reveals socioeconomic barriers to children’s healthcare access
Research published in the Australian Journal of General Practice (AJGP) has revealed mental health and developmental–behavioural issues such as ADHD are the most common paediatric referrals in metropolitan general practices.
But the research also revealed children at higher risk are less likely to get the care they may need.
-
Landmark Australian-led study revises thresholds to diagnose and treat anaemia
In 2014, WEHI researchers began a study at the request of the World Health Organization (WHO), to formally review its global anaemia guidelines that were last updated in 1968.
Study lead and Acting WEHI Deputy Director, Professor Sant-Rayn Pasricha, speaking to Australian Health Journal said while anaemia can be diagnosed by measuring the amount of haemoglobin in the blood, there is currently no consensus on the thresholds that should be used to define the condition.